NCT02207452 - Helium-3 MRI Imaging Study in COPD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 5, 2010

Primary Completion Date

July 4, 2011

Study Completion Date

July 4, 2011

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DEVICE

He-3 MRI

Hyperpolarised helium-3 Magnetic Resonance Imaging (MRI) scan pre-bronchodilator and 1 hour post-bronchodilator (after 1 hour post-bronchodilator assessments/procedures completed).

DRUG

Salbutamol

Salbutamol 5mg nebulised single dose

DRUG

Ipratropium

Ipratropium 500mcg nebulised single dose

DEVICE

MRI

Proton Magnetic Resonance Imaging (MRI) scan pre-bronchodilator and 1 hour post-bronchodilator (after 1 hour post-bronchodilator assessments/procedures completed).

Trial Locations (1)

S10 2JF

GSK Investigational Site, Sheffield